Single-cell protein expression of hiPSC-derived cardiomyocytes using Single-Cell Westerns

Area of Science:

• Stem cell biology
• Cardiovascular research
• Biotechnology

Background:

• Human induced pluripotent stem cells (hiPSCs) can be differentiated into various cell types, including cardiomyocytes (hiPSC-CMs), for disease modeling and drug discovery.
• Current hiPSC-CM differentiation methods yield heterogeneous and immature cell populations, limiting their utility for accurately modeling human diseases.
• Understanding the heterogeneity of hiPSC-CMs at a single-cell level is crucial for improving differentiation protocols and their application in regenerative medicine.

Purpose of the Study:

• To optimize and validate a novel Single-Cell Western method for assessing protein expression in hiPSC-CMs.
• To analyze the heterogeneity of hiPSC-CM subpopulations by quantifying cardiomyocyte subtype-specific proteins (MLC2V and MLC2A) at single-cell resolution.
• To establish a robust platform for protein expression analysis in hiPSC-CMs to enhance their use in disease modeling and regenerative medicine.

Main Methods:

• Optimization and validation of a Single-Cell Western assay.
• Application of the Single-Cell Western method to measure protein expression in hiPSC-CMs.
• Quantification of cardiomyocyte subtype-specific proteins (MLC2V and MLC2A) in individual cells.

Main Results:

• Successful optimization and validation of the Single-Cell Western method for hiPSC-CMs.
• Demonstrated ability to quantify protein expression of MLC2V and MLC2A in distinct hiPSC-CM subpopulations.
• Provided single-cell resolution data on protein expression heterogeneity within differentiated cardiomyocyte populations.

Conclusions:

• The Single-Cell Western method is a powerful tool for dissecting hiPSC-CM heterogeneity at the protein level.
• Improved understanding of hiPSC-CM subpopulations can lead to enhanced differentiation protocols and more accurate disease models.
• This technology holds significant potential for advancing cardiovascular research, drug testing, and regenerative medicine strategies.